The Jungle is self-supported by showing advertisements via Google Adsense.
Please consider disabling your advertisement-blocking plugin on the Jungle to help support the site and let us grow!
We also show significantly less advertisements to registered users, so create your account to benefit from this!
Please consider disabling your advertisement-blocking plugin on the Jungle to help support the site and let us grow!
We also show significantly less advertisements to registered users, so create your account to benefit from this!
Questions or concerns about this ad? Take a screenshot and comment in the thread. We do value your feedback.
WHO chief's dire warning...... Since not enough Sheeple fell for the COVID BS
|
(02-25-2024, 12:47 AM)Lucky2Last Wrote: You speak out of both sides of your mouth, bro. You say you advocate for vaccinations because all age demographics have positive benefits from the vaccine. When I ask you for the data, you can't provide it (but you pretend like you won't). It's [BLEEP] weak sauce, man. If you can't provide the data necessary, then you should just give your opinion and admit it's your belief. It's that simple. Here you go, here's one from 2021 that examines the CFR and strain on burden. I know you're just champing at the bit to tear it apart, so I'll just leave it with you. It does not examine the age brackets up to age 30 because of a lack of data in Japan; as a pretty health country already, they had a lesser overall problem with the pandemic. "Unconditional protection from death was also estimated to be extremely high (>97%) for persons in all age groups." Ko YK, Murayama H, Yamasaki L, Kinoshita R, Suzuki M, Nishiura H. Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan. Emerg Infect Dis. 2022 Sep;28(9):1777-1784. doi: 10.3201/eid2809.220377. Epub 2022 Jul 12. PMID: 35820166; PMCID: PMC9423928. There was also a pediatric study recently completed in the Scandie countries that showed +72% efficacy at 6 months. I know you'll want to send Dr. Poukka an e-mail to explain how his team is wrong, so there's an e-mail for correspondence at the link. "Among adolescents aged 12 to 17 years, BNT162b2, mRNA-1273, and heterologous vaccine schedules provided high protection against COVID-19 hospitalization, with vaccine effectiveness ranging between 72.6% and 86.0% at 6 months of follow-up, including COVID-19–related hospitalizations caused by omicron." https://publications.aap.org/pediatrics/...redirected Anyway, I know this isn't the data you demand, but the fact is that the scholarship on this is getting stronger with each new longer term examination of the outcomes. Now you can get back to saying how wrong I am about everything I say on the topic. “An empty vessel makes the loudest sound, so they that have the least wit are the greatest babblers.”. - Plato
|
Users browsing this thread: |
The Jungle is self-supported by showing advertisements via Google Adsense.
Please consider disabling your advertisement-blocking plugin on the Jungle to help support the site and let us grow!
We also show less advertisements to registered users, so create your account to benefit from this!
Please consider disabling your advertisement-blocking plugin on the Jungle to help support the site and let us grow!
We also show less advertisements to registered users, so create your account to benefit from this!
Questions or concerns about this ad? Take a screenshot and comment in the thread. We do value your feedback.